These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 19722284)
41. The structure of tumor endothelial marker 8 (TEM8) extracellular domain and implications for its receptor function for recognizing anthrax toxin. Fu S; Tong X; Cai C; Zhao Y; Wu Y; Li Y; Xu J; Zhang XC; Xu L; Chen W; Rao Z PLoS One; 2010 Jun; 5(6):e11203. PubMed ID: 20585457 [TBL] [Abstract][Full Text] [Related]
42. Divalent metal ion coordination by residue T118 of anthrax toxin receptor 2 is not essential for protective antigen binding. Scobie HM; Young JA PLoS One; 2006 Dec; 1(1):e99. PubMed ID: 17183731 [TBL] [Abstract][Full Text] [Related]
43. The inhibition of the interaction between the anthrax toxin and its cellular receptor by an anti-receptor monoclonal antibody. Li G; Qu Y; Cai C; Kong Y; Liu S; Zhang J; Zhao J; Fu L; Xu J; Chen W Biochem Biophys Res Commun; 2009 Aug; 385(4):591-5. PubMed ID: 19486894 [TBL] [Abstract][Full Text] [Related]
44. Crystallization and preliminary X-ray analysis of the vWA domain of human anthrax toxin receptor 1. Cai C; Zhao Y; Tong X; Fu S; Li Y; Wu Y; Li X; Lou Z Acta Crystallogr Sect F Struct Biol Cryst Commun; 2011 Jan; 67(Pt 1):64-7. PubMed ID: 21206026 [TBL] [Abstract][Full Text] [Related]
45. Lethal factor of anthrax toxin binds monomeric form of protective antigen. Chvyrkova I; Zhang XC; Terzyan S Biochem Biophys Res Commun; 2007 Aug; 360(3):690-5. PubMed ID: 17617379 [TBL] [Abstract][Full Text] [Related]
46. Recombinant HSA-CMG2 Is a Promising Anthrax Toxin Inhibitor. Li L; Guo Q; Liu J; Zhang J; Yin Y; Dong D; Fu L; Xu J; Chen W Toxins (Basel); 2016 Jan; 8(1):. PubMed ID: 26805881 [TBL] [Abstract][Full Text] [Related]
47. The protective antigen component of anthrax toxin forms functional octameric complexes. Kintzer AF; Thoren KL; Sterling HJ; Dong KC; Feld GK; Tang II; Zhang TT; Williams ER; Berger JM; Krantz BA J Mol Biol; 2009 Sep; 392(3):614-29. PubMed ID: 19627991 [TBL] [Abstract][Full Text] [Related]
48. Acid induced unfolding of anthrax protective antigen. Gupta PK; Kurupati RK; Chandra H; Gaur R; Tandon V; Singh Y; Maithal K Biochem Biophys Res Commun; 2003 Nov; 311(1):229-32. PubMed ID: 14575718 [TBL] [Abstract][Full Text] [Related]
50. Anthrax toxin protective antigen--insights into molecular switching from prepore to pore. Bann JG Protein Sci; 2012 Jan; 21(1):1-12. PubMed ID: 22095644 [TBL] [Abstract][Full Text] [Related]
51. Anthrax toxin receptor 1/tumor endothelial marker 8: mutation of conserved inserted domain residues overrides cytosolic control of protective antigen binding. Ramey JD; Villareal VA; Ng C; Ward SC; Xiong JP; Clubb RT; Bradley KA Biochemistry; 2010 Aug; 49(34):7403-10. PubMed ID: 20690680 [TBL] [Abstract][Full Text] [Related]
52. Receptors of anthrax toxin and cell entry. van der Goot G; Young JA Mol Aspects Med; 2009 Dec; 30(6):406-12. PubMed ID: 19732789 [TBL] [Abstract][Full Text] [Related]
53. Receptor-enhanced immunogenicity of anthrax protective antigen is primarily mediated by capillary morphogenesis Protein-2. Verma A; Moayeri M; Mocca CP; O'Mard D; Ma Q; Leppla SH; Burns DL Vaccine; 2022 Jul; 40(32):4318-4321. PubMed ID: 35710508 [TBL] [Abstract][Full Text] [Related]